AI filing briefs

Calumet, Inc. /DE (CLMT)

CLMT 8-K filings, explained

Every material Form 8-K Calumet, Inc. /DE has filed with the SEC since August 07, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs on record4since Aug 07, 2026
Latest filingNov 06, 2026earnings
High impact (4-5)1of 4 briefs
ToneMixed3Neutral1
earnings 2financing 2

2026

Nov 6, 8:01 AM ET

Calumet Q3 sales rise to $1.68 billion; net income falls to $273.3 million

Mixed earnings 2.02

Calumet reported third-quarter 2026 results, with sales of $1.68 billion, up from $1.08 billion a year earlier. Net income fell to $273.3 million from $313.4 million, and basic earnings per share were $2.91 versus $3.61, after non-cash derivative and RINs-related charges. Adjusted EBITDA rose to $322.0 million from $69.6 million, and the company said it has retired about $265 million of debt since July.

  • Q3 2026 sales of $1.68 billion vs. $1.08 billion in Q3 2025; net income of $273.3 million vs. $313.4 million
  • Basic EPS of $2.91 vs. $3.61 a year earlier; net income attributable to common shareholders of $256.4 million
  • Adjusted EBITDA of $322.0 million vs. $69.6 million; Adjusted EBITDA with Tax Attributes of $347.2 million vs. $92.5 million
  • Non-cash items included a $113.8 million unrealized derivatives loss and $176.7 million of RINs-related items; $150 million of 2028 Notes were redeemed on October 25, 2026
Read the filing on SEC.gov ↗
Sep 14, 5:46 PM ET

Calumet amends credit agreement, raising commitments from $500.0 million to $600.0 million

Neutral financing Written later 1.012.03

Calumet, Inc. entered into an amendment to its credit agreement on September 11, 2026, increasing lender commitments from $500.0 million to $600.0 million, subject to borrowing base limitations. A related amendment to its Monetization Master Agreement with J. Aron & Company LLC was made to permit the larger credit facility. The filing does not state the reasons for the change or any effect on earnings, and shareholders can expect more borrowing capacity under the facility.

  • Credit agreement commitments rise from $500.0 million to $600.0 million, subject to borrowing base limitations
  • Eleventh Amendment to the Third Amended and Restated Credit Agreement dated September 11, 2026, with Bank of America, N.A. as administrative agent
  • Fourth Amendment to the Monetization Master Agreement with J. Aron & Company LLC, dated September 11, 2026, permits the increase
  • Filed under Items 1.01, 2.03 and 9.01; signed by David Lunin, Executive Vice President and Chief Financial Officer, on September 14, 2026
Read the filing on SEC.gov ↗
Sep 1, 4:20 PM ET

Calumet cuts DOE-guaranteed loan to $815.8 million and expansion capital to $137 million

Mixed financing Written later 1.017.01

Calumet's subsidiary Montana Renewables amended its loan guarantee agreement with the U.S. Department of Energy on August 28, 2026, reducing the maximum loan principal to $815.8 million from $1.44 billion as the Great Falls expansion shifts to repurposing existing equipment. The company says remaining expansion capital is $137 million, to be funded from Montana Renewables earnings with no third-party equity, and targets about 200 million gallons of annual SAF production by year-end 2028. Lower capital needs and no dilution stand against a smaller project, which the company says captures about 70% of the originally expected benefit.

  • Maximum DOE loan principal reduced to $815.8 million and capitalized interest cap to $232.8 million.
  • Remaining expansion capital is $137 million, versus the $1.2 billion original Phase 2 plan.
  • Phase 2 DOE funding cut from up to $658 million to a single final draw of $34 million.
  • Target of about 200 million gallons of annual SAF production and 17,000 barrels per day of total product sales by year-end 2028.
Read the filing on SEC.gov ↗
Aug 7, 8:05 AM ET

Calumet Q2 2026 net loss narrows to $95.9 million; Adjusted EBITDA rises to $159.3 million

Mixed earnings Written later 2.02

Calumet reported a second-quarter 2026 net loss of $95.9 million, or $1.09 per basic share, compared with a net loss of $147.9 million, or $1.70 per share, a year earlier. Sales rose to $1,445.1 million from $1,026.6 million, and Adjusted EBITDA rose to $159.3 million from $55.1 million, though the filing notes non-cash RINs expense of $163.6 million weighed on results and the six-month net loss widened to $412.9 million.

  • Q2 2026 net loss of $95.9 million vs. $147.9 million in Q2 2025; basic EPS of $(1.09) vs. $(1.70)
  • Q2 2026 sales of $1,445.1 million vs. $1,026.6 million; Adjusted EBITDA of $159.3 million vs. $55.1 million
  • Specialty Products and Solutions Adjusted EBITDA of $161.7 million vs. $66.8 million; Montana/Renewables Adjusted EBITDA with Tax Attributes of $26.6 million vs. $16.3 million
  • On July 15, 2026, the company redeemed $100 million of 9.75% Senior Notes due 2028; $115 million of debt retirement in July was cited
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Calumet, Inc. /DE filing is on SEC EDGAR ↗. 8-K briefs of other companies →